Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T4998 |
Cefpodoxime proxetil
|
Antibacterial; Antibiotic | Microbiology/Virology |
Cefpodoxime Proxetil 是一种口服的广谱型抗生素。它与青霉素结合蛋白结合,抑制肽聚糖的合成,干扰细菌细胞壁的生物合成。 | |||
T4998L |
Cefpodoxime (free acid)
|
Others | Others |
Cefpodoxime (free acid) 是一种口服的第三代头孢菌素抗生素。除铜绿假单胞菌、肠球菌和脆弱拟杆菌外,它对大多数革兰氏阳性和革兰氏阴性微生物均有效。 | |||
T41106 |
Cefpodoxime proxetil impurity B
|
||
Cefpodoxime proxetil impurity B is a constituent found in Cefpodoxime proxetil, which is a third-generation cephalosporin. This compound, known as Cefpodoxime Proxetil, is a highly effective oral antibiotic with a broad spectrum of activity. | |||
T4998L2 |
Cefpodoxime sodium
R3746,R 3763,R 3746,R-3746,R-3763 |
||
Cefpodoxime sodium is a third generation cephalosporin antibiotic agent. It targets gram-positive and gram-negative bacteria, especially those responsible for otitis media and pharyngitis. | |||
T69797 |
ETX0282
|
||
ETX0282 is an orally available, broad spectrum inhibitor of class A and C β-lactamases. Entasis is developing ETX0282 in combination with cefpodoxime proxetil, an orally available cephalosporin approved for treatment of a variety of bacterial infections. |